fda announcement semaglutide Big news from the last week: Wegovy (semaglutide) was approved for a new use, other than weight loss The Wild East of semaglutide

What do you think are the main drivers behind this more constructive inflation outlook, especially taking into account the market's prevailing concerns about persistent price pressures

Semaglutide: Single-Receptor Approach Semaglutide activates the GLP-1 receptor, producing the following effects: Appetite suppression through direct action on hypothalamic neurons that control hunger signaling Delayed gastric emptying that promotes prolonged feelings of fullness after meals Enhanced glucose-dependent insulin secretion from pancreatic beta cells Reduced glucagon secretion (different from glucagon receptor activation) that lowers hepatic glucose output Potential neuroprotective effects currently being studied in Alzheimers disease trials Research by Blundell et al

Usage: Take 1 serving (1 capsule) daily with a meal

The Dexcom G7 System is also intended to autonomously communicate with digitally connected devices, including automated insulin dosing (AID) systems